---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-074743"
form_type: "8-K"
ticker: "DERM"
cik: "0001867066"
company_name: "Journey Medical Corp"
filed_at: "2024-06-25T23:59:59+00:00"
generated_at: "2026-06-01T02:18:42.910304+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Journey Medical shareholders approve 3M share increase and 10-year extension of 2015 stock plan

## Summary
- Stockholders approved an amendment to the 2015 Stock Incentive Plan adding 3,000,000 shares, for a total of 10,642,857 shares authorized.
- Plan expiration extended by 10 years to May 27, 2035.
- All five director nominees re-elected; KPMG LLP ratified as auditor for 2024.
- Proposals received strong support: ~95% of votes cast for plan amendment, 99.9% for auditor ratification.
- The plan amendment became effective immediately upon stockholder approval on June 25, 2024.

## SEC filing metadata
- accession: 0001104659-24-074743
- form_type: 8-K
- ticker: DERM
- cik: 0001867066
- company_name: Journey Medical Corp
- filed_at: 2024-06-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1867066/000110465924074743/0001104659-24-074743-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1867066/000110465924074743/tm2418215d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-074743
- JSON: https://secwatch.observer/filing/0001104659-24-074743.json
- Plain text: https://secwatch.observer/filing/0001104659-24-074743.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.